Cai Q, Guo R, Chen D, Deng Z, Gao J
J Nanobiotechnology. 2025; 23(1):178.
PMID: 40050980
PMC: 11884119.
DOI: 10.1186/s12951-025-03254-9.
El-Sahli S, Manturthi S, Durocher E, Bo Y, Akman A, Sannan C
ACS Pharmacol Transl Sci. 2025; 8(2):460-469.
PMID: 39974646
PMC: 11833720.
DOI: 10.1021/acsptsci.4c00597.
Krauss J, Georgieva R, Karabaliev M, Hackmann M, Rerkshanandana P, Chaiwaree S
Nanomaterials (Basel). 2025; 15(3).
PMID: 39940163
PMC: 11820349.
DOI: 10.3390/nano15030187.
Wang L, Zhou W, Chen H, Jia X, Zheng P, Jiang H
Nat Commun. 2025; 16(1):899.
PMID: 39837887
PMC: 11751284.
DOI: 10.1038/s41467-025-56257-3.
Wang M, Yu F, Zhang Y
Mol Cancer. 2025; 24(1):26.
PMID: 39827147
PMC: 11748575.
DOI: 10.1186/s12943-024-02214-5.
Wearable electrodriven switch actively delivers macromolecular drugs to fundus in non-invasive and controllable manners.
Qin X, Shi H, Li H, Chu B, Zhang J, Wen Z
Nat Commun. 2025; 16(1):33.
PMID: 39747871
PMC: 11695998.
DOI: 10.1038/s41467-024-55336-1.
Hybrid Cell Membrane-Engineered Nanocarrier for Triple-Action Strategy to Address Pseudomonas aeruginosa Infection.
Zhang S, Chen T, Lu W, Lin Y, Zhou M, Cai X
Adv Sci (Weinh). 2024; 12(6):e2411261.
PMID: 39721013
PMC: 11809413.
DOI: 10.1002/advs.202411261.
Nanoparticles Codelivering mRNA and SiRNA for Simultaneous Restoration and Silencing of Gene/Protein Expression In Vitro and In Vivo.
Manturthi S, El-Sahli S, Bo Y, Durocher E, Kirkby M, Popatia A
ACS Nanosci Au. 2024; 4(6):416-425.
PMID: 39713729
PMC: 11659891.
DOI: 10.1021/acsnanoscienceau.4c00040.
Evaluation of Drug Effectiveness and Controlled Release Profiles of Clay Minerals Loaded with Anti-Carcinogenic Agent as a Drug Delivery System on Leukemia.
Duran M, Kaga E
Cancer Manag Res. 2024; 16:1775-1792.
PMID: 39678044
PMC: 11646428.
DOI: 10.2147/CMAR.S491805.
Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy.
Zhang H, Li Y, Huang J, Shen L, Xiong Y
Acta Pharm Sin B. 2024; 14(11):4717-4737.
PMID: 39664426
PMC: 11628863.
DOI: 10.1016/j.apsb.2024.07.021.
Modulating GSK3β Phosphorylation: Bio-Corona Protective Effects Against Silica Nanoparticle-Induced Neurotoxicity.
Qiao X, Cui X, Chen C
Environ Health (Wash). 2024; 2(2):62-64.
PMID: 39474101
PMC: 11504453.
DOI: 10.1021/envhealth.4c00002.
Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium.
Nayak T, Chrastina A, Valencia J, Cordova-Robles O, Yedidsion R, Buss T
Nat Nanotechnol. 2024; 20(1):144-155.
PMID: 39379614
DOI: 10.1038/s41565-024-01786-z.
Realizing active targeting in cancer nanomedicine with ultrasmall nanoparticles.
Lima A, Justo G, Sousa A
Beilstein J Nanotechnol. 2024; 15:1208-1226.
PMID: 39376728
PMC: 11457047.
DOI: 10.3762/bjnano.15.98.
A nanocarbon-enabled hybridization strategy to construct pharmacologically cooperative therapeutics for augmented anticancer efficacy.
Wang H, Liu X, Yan X, Du Y, Pu F, Ren J
Chem Sci. 2024; .
PMID: 39290590
PMC: 11403576.
DOI: 10.1039/d4sc05280c.
Transvascular transport of nanocarriers for tumor delivery.
Li X, Hu Y, Zhang X, Shi X, Parak W, Pich A
Nat Commun. 2024; 15(1):8172.
PMID: 39289401
PMC: 11408679.
DOI: 10.1038/s41467-024-52416-0.
Targeted anti-angiogenesis therapy for advanced osteosarcoma.
Zhang Q, Xia Y, Wang L, Wang Y, Bao Y, Zhao G
Front Oncol. 2024; 14:1413213.
PMID: 39252946
PMC: 11381227.
DOI: 10.3389/fonc.2024.1413213.
Biomimetic Nucleic Acid Drug Delivery Systems for Relieving Tumor Immunosuppressive Microenvironment.
Yan W, Cao Y, Yin Q, Li Y
Pharmaceutics. 2024; 16(8).
PMID: 39204373
PMC: 11360391.
DOI: 10.3390/pharmaceutics16081028.
Predicting tissue distribution and tumor delivery of nanoparticles in mice using machine learning models.
Mi K, Chou W, Chen Q, Yuan L, Kamineni V, Kuchimanchi Y
J Control Release. 2024; 374:219-229.
PMID: 39146980
PMC: 11886896.
DOI: 10.1016/j.jconrel.2024.08.015.
Self-Reporting Therapeutic Protein Nanoparticles.
Berardi A, Raymond J, Chang A, Mauser A, Lahann J
ACS Appl Mater Interfaces. 2024; 16(33):43350-43363.
PMID: 39106360
PMC: 11898306.
DOI: 10.1021/acsami.4c09114.
HiViPore: a highly viable in-flow compression for a one-step cell mechanoporation in microfluidics to induce a free delivery of nano- macro-cargoes.
Maremonti M, Panzetta V, Netti P, Causa F
J Nanobiotechnology. 2024; 22(1):441.
PMID: 39068464
PMC: 11282774.
DOI: 10.1186/s12951-024-02730-y.